DRG1 anticorps
-
- Antigène Voir toutes DRG1 Anticorps
- DRG1 (Developmentally Regulated GTP Binding Protein 1 (DRG1))
-
Reactivité
- Humain, Souris
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp DRG1 est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Attributs du produit
- Polyclonal Antibody
- Purification
- Affinity purification
- Immunogène
- Recombinant protein of human DRG1
- Isotype
- IgG
- Top Product
- Discover our top product DRG1 Anticorps primaire
-
-
- Indications d'application
- WB 1:500-1:2000, IHC 1:50-1:200
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.5 mg/mL
- Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Antigène
- DRG1 (Developmentally Regulated GTP Binding Protein 1 (DRG1))
- Autre désignation
- DRG1 (DRG1 Produits)
- Synonymes
- anticorps NEDD3, anticorps wu:fb06g12, anticorps zgc:64124, anticorps xdrg, anticorps xdrg1, anticorps MGC122865, anticorps AA408859, anticorps AI132520, anticorps Nedd3, anticorps developmentally regulated GTP binding protein 1, anticorps developmentally regulated GTP binding protein 1 L homeolog, anticorps DRG1, anticorps Drg1, anticorps drg1, anticorps drg1.L
- Sujet
- DRG1 (developmentally regulated GTP binding protein 1), also known as NEDD3 (neural precursor cell expressed developmentally down-regulated protein 3), is a 367 amino acid protein that localizes to the cytoplasm and belongs to the GTP1/OBG family. Expressed at high levels in heart, kidney and skeletal muscle and at lower levels in brain, liver, placenta, lung, colon and spleen, DRG1 binds to TAL1 and TAL2 and is thought to play a role in cell proliferation and differentiation, as well as in apoptosis, suggesting a role in tumor formation and metastasis. DRG1 is subject to polyubiquitination and sumoylation, the former of which induces proteolytic degradation. The gene encoding DRG1 maps to human chromosome 22, which houses over 500 genes and is the second smallest human chromosome. Mutations in several of the genes that map to chromosome 22 are involved in the development of Phelan-McDermid syndrome, Neurofibromatosis type 2, autism and schizophrenia.
- Poids moléculaire
- 41 kDa
- UniProt
- Q9Y295
-